key: cord-0890581-nhq2pern
authors: Rajendram, Rajkumar; Kharal, Ghulam Abbas; Mahmood, Naveed; Kharal, Mubashar
title: Systemic thromboemboli in patients with Covid-19 may result from paradoxical embolization
date: 2020-09-01
journal: Thromb Res
DOI: 10.1016/j.thromres.2020.08.045
sha: bf2eae6a5957509b2ad5c1b254ac488747af53ed
doc_id: 890581
cord_uid: nhq2pern

There is increasing evidence that Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection causes an unusual pneumonia and a pro-coagulant state that significantly increases the risk of arterial and venous thromboembolism. We hypothesize that, in select patients, some complications of COVID-19 may be due to right-to-left (RTL) shunt. Shunt may be intra-pulmonary, or extra-pulmonary, and can cause paradoxical embolization, hypoxia and platypnoea orthodeoxia. Saline microbubble contrast echocardiography is a minimally invasive, inexpensive, bedside test that can detect, quantify, and define the anatomical substrate of intra-pulmonary and intra-cardiac shunts. The prevalence of patent foramen ovale (PFO) in the general population is high (20–30%) but is even higher in patients who have a stroke (50%). Thus, the striking absence of data on patients with PFO who develop COVID-19 suggests that this is being under-diagnosed. This may be because physicians and sonographers currently feel that screening for shunt is unnecessary. This could be an unintended consequence of guidance from several specialist societies to defer procedures to close PFO until after the pandemic. This may be counterproductive. Patients with shunt may be at particularly high risk of complications from COVID-19 and interventions to minimise RTL shunt could prevent paradoxical embolization and improve hypoxia in select high risk patients with COVID-19.

There is increasing evidence that Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection causes an unusual pneumonia and a pro-coagulant state that significantly increases the risk of arterial and venous thromboembolism. We hypothesise that, in select patients, some complications of COVID-19 may be due to right-to-left (RTL) shunt. Shunt may be intra-pulmonary, or extra-pulmonary, and can cause paradoxical embolization, hypoxia and platypnoea orthodeoxia. Saline microbubble contrast echocardiography is a minimally invasive, inexpensive, bedside test that can detect, quantify, and define the anatomical substrate of intra-pulmonary and intra-cardiac shunts. The prevalence of patent foramen ovale (PFO) in the general population is high (20-30%) but is even higher in patients who have a stroke (50%). Thus, the striking absence of data on patients with PFO who develop COVID-19 suggests that this is being under-diagnosed. This may be because physicians and sonographers currently feel that screening for shunt is unnecessary. This could be an unintended consequence of guidance from several specialist societies to defer procedures to close PFO until after the pandemic. This may be counterproductive. Patients with shunt may be at particularly high risk of complications from COVID-19 and interventions to minimise RTL shunt could prevent paradoxical embolization and improve hypoxia in select high risk patients with COVID-19.

The studies describing the incidence of thrombotic complications in patients with Coronavirus Disease 2019 (COVID-19) [1, 2] and the scoping review of the thrombosis risk associated with COVID-19 by Al-Ani and colleagues [3] are of great interest. They report that the incidence of venous thromboembolism in patients with COVID-19 is very high [1] [2] [3] .

Whilst arterial thromboemboli (stroke, myocardial infarction and other systemic emboli) are thought to be less common [1] [2] [3] , silent cerebral infarcts were revealed in 3 patients when magnetic resonance imaging (MRI) was performed in 13 encephalopathic patients with COVID-19 [4] . So, the true incidence of stroke in COVID-19 is probably under appreciated.

Furthermore, in a series of 32 patients with stroke and COVID-19, cryptogenic stroke (65.6%) was more common than in contemporary controls (30.4%) [5] . This may reflect incomplete assessment. However, data on the risk factors for cryptogenic stroke in COVID-19 are limited. So, atypical or novel mechanisms could cause stroke in patients infected with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) [3] . In this context, it is important to note that, in Yaghi and colleagues' series of 32 patients, cryptogenic stroke was associated with a trend towards higher D-dimer (median 4.8 µg/ml versus 2.1 µg/ml, p=0.109) [5] .

These observations contribute to the increasing evidence that SARS-CoV-2 infection causes a pro-coagulant state that significantly increases the risk of thromboembolism. Whilst any infection may induce a pro-coagulant state, the risks of microvascular thrombosis and thromboembolism are particularly high in patients with pulmonary infections [6] . Indeed, the histopathological features of COVID-19 pneumonia include diffuse alveolar damage (i.e. interstitial pneumonia) with widespread thrombotic microvascular involvement [7] .

It has previously been suggested that a pro-coagulant state could cause small, 'silent' pulmonary emboli that result in interstitial pneumonia, interstitial lung disease, and progressive lung fibrosis [8] . This process could be relevant in the pathogenesis of interstitial pneumonia in COVID-19.

Pulmonary microvascular thrombosis should increase dead space. However, some patients have more right-to-left (RTL) shunt than expected for the degree of injury apparent on imaging of the lungs [9] [10] [11] . The mean RTL shunt fraction of a series of patients with Covid-19 described by Gattinoni and colleagues was 0.50 ± 0.11 despite relatively preserved pulmonary compliance (50.2 ± 14.3 ml/cmH2O) [11] . We hypothesize that the development of RTL shunt in select patients with COVID-19 may contribute to the increased the risk of systemic thromboembolism [9, 10] . Al-Ani and colleagues [3] comprehensively reviewed the existing literature for potential pathogenic mechanisms which could account for the increased risk of thromboembolism in patients with COVID-19.

However, discussion of paradoxical embolization, a well-recognised cause of stroke and systemic embolization [9, 10, 12] , was conspicuously absent from their scoping review. We therefore suspect that this phenomenon is being overlooked during the current pandemic.

Patients with COVID-19 pneumonia will almost certainly have some intra-pulmonary shunt [10] [11] [12] . Previous studies have reported that the prevalence of intra-pulmonary shunt is higher in patients with cryptogenic stroke (22%) than in matched controls (10%) [13] . This suggests that intra-pulmonary shunt could facilitate ischaemic cerebrovascular events [13] . few data to guide management of patients with extrapulmonary shunt. However, the standard approach to refractory hypoxia may exacerbate ARTLIAS whilst trying to reduce intrapulmonary shunt [16, 17] . So management should be guided by the pathophysiology of shunt and should aim to reduce both intra-and extrapulmonary shunt. Ideally these subgroup analyses should correlate blood gases, lung mechanics, thromboembolism and outcomes of COVID-19 with the severity of shunt. Intra-pulmonary and intra-cardiac shunt can be detected, quantified and distinguished with saline microbubble contrast echocardiography. This is an inexpensive, minimally invasive bedside test that can be performed during a standard echocardiographic examination.

Although patients with COVID-19 frequently require echocardiography; physicians and sonographers may feel that screening for shunt is currently unnecessary [10] . This is because several specialist societies have recommended that PFO closure should be deferred during the J o u r n a l P r e -p r o o f Journal Pre-proof pandemic [6] . This may be counterproductive. Despite the absence of specific data in patients with COVID-19; prevention of recurrence of PFO-related stroke and treatment of hypoxia due to RTL inter-atrial shunt are well recognised indications for PFO closure [10, 12] .

Patients with shunt may be at high risk of complications from COVID-19 [9, 10] .

Therefore, if a patient with COVID-19 is having echocardiography anyway, adding a microbubble contrast study could yield significant, clinically relevant information for almost no extra cost. In the absence of another specific indication for echocardiography, we In patients with COVID-19 the presence of shunt will influence respiratory management [9, 10] and may reduce the threshold for treatment with anticoagulation. Furthermore, elimination of the anatomical substrate for the shunt, if possible, by closure of an atrial septal defect or PFO, for example, could prevent paradoxical embolization and improve hypoxia in select high risk patients with COVID-19 [9, 10] . Whilst further studies are required to support this PFO closure in this context, we suggest that it is important to screen for RTL shunt in patients with COVID-19 [9, 10] . 

Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in

Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis

Thrombosis risk associated with COVID-19

A scoping review

Neurologic features in severe SARS-CoV-2 infection

SARS-CoV-2 and Stroke in a New York Healthcare System

Is infection an independent risk factor for venous thromboembolism? A population-based, case-control study

Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study

Venous thromboembolism and risk of idiopathic interstitial pneumonia: a nationwide study

Rethinking the respiratory paradigm of COVID-19: a 'hole' in the argument

The importance of detection and percutaneous closure of patent foramen ovale during the COVID-19 pandemic

Acute Respiratory Distress Syndrome

Epidemiology of Patent Foramen Ovale in General Population and in Stroke Patients: A Narrative Review

Intrapulmonary shunt is a potentially unrecognized cause of ischemic stroke and transient ischemic attack

Clinical Characteristics and Outcomes of COVID-19 Patients With a History of Stroke in Wuhan

Severe Acute Proximal

Pulmonary Embolism and COVID-19: A Word of Caution

Prevalence and prognosis of shunting across patent foramen ovale during acute respiratory distress syndrome

Hemodynamic and respiratory factors that influence the opening of patent foramen ovale in mechanically ventilated patients